Ilya Yuffa

EVP&Pres Ilya Yuffa sells 2,500 LLY shares at $1,150.77 under pre-arranged 10b5-1 plan; retains 29,804 shares.

Ilya Yuffa, EVP&President of LLY USA&Global Capab, sold 2,500 shares (7.7% of pre-transaction holdings) for $2,876,925.00 on 2026-06-10 under a 10b5-1 trading plan adopted on 2026-02-13, meaning this sale was scheduled rather than discretionary. His prior LLY sale on 2025-05-14 was followed by 30d returns of +9.4% and 90d returns of -14.7%, indicating the stock moved substantially higher after that sale. The current price of $1,160.95 is 1.8% below the 52-week high of $1182.73 and 17.3% higher than 30 days prior, yet Yuffa retains 29,804 shares post-transaction. This scheduled transaction reflects plan execution rather than a discretionary positioning decision.

EVP Yuffa Ilya sold 1,250 shares of LLY at $749.24, retaining 27,509 shares post-transaction.

Yuffa Ilya, EVP & President of Eli Lilly International, executed a sale of 1,250 shares at $749.24 on 2025-05-14, reducing holdings from 28,759 to 27,509 shares (a -4.3% reduction). The sale occurred near the upper end of the 52-week range ($715.56–$960.02), though the stock currently trades at $733.29, down 23.6% from its 52-week high and 13.2% over the trailing 90-day period. The executive retained substantial holdings of 27,509 shares post-transaction, indicating continued material exposure to the company. With annual revenue growth at +32.0% and strong quarterly net income of $2.8B, the company maintains robust financial performance despite the elevated P/E of 62.57, suggesting market expectations have priced in significant future growth. The modest transaction size and incomplete liquidation pattern provide limited directional signal on management conviction.